Testicular Cancer Clinical Trials

Find Testicular Cancer Clinical Trials Near You

Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity (TG-BIL)

Status: Recruiting
Location: See location...
Intervention Type: Biological, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a study exploring measurable markers in the blood of patients with testicular tumors. The investigators will focus on the importance of measuring and analyzing these markers for their prognostic value and predictive response to treatment.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:

• Adult patient, male, with a clinical and biological diagnosis of germ cell tumor of the testis in pre-orchidectomy, at the stage of the disease and any histological subtype of germ cell tumor

• Affiliation with a Social Security organization

• Able to give informed consent to participate in the research.

Locations
Other Locations
France
CHU Clermont-Ferrand
RECRUITING
Clermont-ferrand
Contact Information
Primary
Lise LACLAUTRE
promo_interne_drci@chu-clermontferrand.fr
0473754963
Time Frame
Start Date: 2026-01-01
Estimated Completion Date: 2029-01-01
Participants
Target number of participants: 20
Treatments
Other: Patient with a testicular cell germ tumor
All patients will have the same samples, at the time of orchidectomy, then during chemotherapy and during follow-up.
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Clermont-Ferrand

This content was sourced from clinicaltrials.gov